Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer

Authors

  • Mitchell S. Anscher Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, USA
  • Michael G. Chang Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, USA; Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, VA, USA
  • Drew Moghanaki Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, USA; Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, VA, USA
  • Mihaela Rosu Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, USA
  • Ross B. Mikkelsen Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, USA
  • Diane Holdford The Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA
  • Vicki Skinner The Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA
  • B. Mayer Grob Department of Surgery (Urology), Virginia Commonwealth University, Richmond, VA, USA
  • Arun Sanyal Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA
  • Aiping Wang Department of Biostatistics, Virginia Commonwealth University, Richmond, VA, USA
  • Nitai D. Mukhopadhyay Department of Biostatistics, Virginia Commonwealth University, Richmond, VA, USA

DOI:

https://doi.org/10.1080/0284186X.2016.1223882

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2016-12-01

How to Cite

Anscher, M. S., Chang, M. G., Moghanaki, D., Rosu, M., Mikkelsen, R. B., Holdford, D., … Mukhopadhyay, N. D. (2016). Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer. Acta Oncologica, 55(12), 1500–1502. https://doi.org/10.1080/0284186X.2016.1223882